Geode Capital Management LLC Boosts Stake in Sabra Healthcare REIT, Inc. $SBRA

Geode Capital Management LLC increased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 2.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,018,556 shares of the real estate investment trust’s stock after acquiring an additional 198,118 shares during the period. Geode Capital Management LLC owned about 2.81% of Sabra Healthcare REIT worth $132,949,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of SBRA. Allstate Corp bought a new position in Sabra Healthcare REIT in the 4th quarter worth $492,000. Legal & General Group Plc raised its holdings in Sabra Healthcare REIT by 16.5% in the 4th quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock worth $27,031,000 after purchasing an additional 201,667 shares during the period. New Age Alpha Advisors LLC bought a new position in Sabra Healthcare REIT in the 4th quarter worth $866,000. Hantz Financial Services Inc. increased its stake in Sabra Healthcare REIT by 102.5% in the 4th quarter. Hantz Financial Services Inc. now owns 8,010 shares of the real estate investment trust’s stock worth $152,000 after buying an additional 4,054 shares in the last quarter. Finally, Jefferies Financial Group Inc. purchased a new stake in Sabra Healthcare REIT in the 4th quarter worth $321,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 2.3%

SBRA opened at $17.67 on Friday. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The firm has a market cap of $4.46 billion, a P/E ratio of 28.05, a P/E/G ratio of 1.36 and a beta of 0.64. Sabra Healthcare REIT, Inc. has a 12 month low of $17.17 and a 12 month high of $21.28. The stock has a 50-day moving average of $20.17 and a 200 day moving average of $19.69.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. The business had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.8%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on SBRA shares. Weiss Ratings lowered Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Friday, May 1st. Cantor Fitzgerald raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Citizens Jmp raised their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Monday, May 18th. Finally, Wells Fargo & Company raised their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Monday. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $22.40.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.